Quadrant Capital Group’s iShares Biotechnology ETF IBB Stock Holding History

Quadrant Capital Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-800	Closed	-$135K	–	1850
2026 Q1	$135K	Hold	800	–	–	﹤0.01%	1390
2025 Q4	$135K	Buy	+800	New	+$130K	﹤0.01%	1411
2024 Q4	–	Sell	-420	Closed	-$61.2K	–	2764
2024 Q3	$61.2K	Hold	420	–	–	﹤0.01%	1343
2024 Q2	$57.6K	Hold	420	–	–	﹤0.01%	1332
2024 Q1	$57.6K	Hold	420	–	–	﹤0.01%	1308
2023 Q4	$57.1K	Hold	420	–	–	﹤0.01%	1320
2023 Q3	$51.4K	Buy	+420	New	+$53.4K	0.01%	1249
2023 Q2	–	Sell	-164	Closed	-$21.2K	–	2726
2023 Q1	$21.2K	Buy	+164	New	+$21.5K	﹤0.01%	1674
2022 Q4	–	Sell	-40	Closed	-$5K	–	2784
2022 Q3	$5K	Sell	40 -45	-53%	-$5.59K	﹤0.01%	2134
2022 Q2	$10K	Hold	85	–	–	﹤0.01%	1654
2022 Q1	$11K	Sell	85 -100	-54%	-$13K	﹤0.01%	1600
2021 Q4	$28K	Hold	185	–	–	﹤0.01%	1141
2021 Q3	$30K	Hold	185	–	–	﹤0.01%	1067
2021 Q2	$30K	Hold	185	–	–	﹤0.01%	1037
2021 Q1	$28K	Hold	185	–	–	﹤0.01%	1032
2020 Q4	$28K	Hold	185	–	–	0.01%	960
2020 Q3	$25K	Sell	185 -840	-82%	-$114K	0.01%	874
2020 Q2	$140K	Buy	1,025 +690	+206%	+$88K	0.03%	355
2020 Q1	$36K	Hold	335	–	–	0.01%	1024
2019 Q4	$39K	Buy	+335	New	+$37.4K	﹤0.01%	1457
2018 Q4	–	Sell	-1,050	Closed	-$128K	–	2237
2018 Q3	$128K	Hold	1,050	–	–	0.04%	338
2018 Q2	$115K	Hold	1,050	–	–	0.04%	360
2018 Q1	$111K	Buy	+1,050	New	+$116K	0.04%	377

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Quadrant Capital Group's IBB Position: Q2 2026 in Review

Quadrant Capital Group sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 800 shares — an estimated $135K sold.

Quadrant Capital Group first reported a position in IBB in Q1 2018 and held it in 23 quarters. The position peaked at $140K in Q2 2020. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Quadrant Capital Group reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
Quadrant Capital Group sold 800 iShares Biotechnology ETF shares in Q2 2026, an estimated $135K.
Quadrant Capital Group first reported a position in iShares Biotechnology ETF in Q1 2018 and held it in 23 quarters.
Quadrant Capital Group's iShares Biotechnology ETF position peaked at $140K in Q2 2020.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.